Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
46-60 of 383
Making Mechanism-Based Treatment Decisions in cGVHD
Project Oncology®Making Mechanism-Based Treatment Decisions in cGVHD
Brian P. McDonough, MD, FAAFP
Alicia Lieberman, MD, MS
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Clinician's RoundtableColorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Brian P. McDonough, MD, FAAFP
Carolyn Rutter, PhD
Gloria Coronado, PhD
Preventing Colorectal Cancer with Smart Screening
Clinician's RoundtablePreventing Colorectal Cancer with Smart Screening
Harish Gagneja, MD
Supplement Use for Colorectal Cancer Prevention: Insights from NCCN Guidelines
Clinician's RoundtableSupplement Use for Colorectal Cancer Prevention: Insights from NCCN Guidelines
Reid Ness, MD
Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Clinician's RoundtableAdherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Mallik Greene, PhD
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's RoundtableWeighing the Environmental Impact of Colorectal Cancer Screening Methods
Peter Buch, MD, FACG, AGAF, FACP
A. Mark Fendrick, MD
- advertisement
Blood-Based Screening for Colorectal Cancer: Benefits and Limitations
Clinician's RoundtableBlood-Based Screening for Colorectal Cancer: Benefits and Limitations
Aasma Shaukat, MD, MPH
ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Project Oncology®ctDNA-Guided Adjuvant Atezolizumab in MIBC: IMvigor011 Insights
Charles Turck, PharmD, BCPS, BCCCP
Guru P. Sonpavde, MD
Examining the Role of Bacterial Biofilms in Colorectal Cancer Screening
Clinician's RoundtableExamining the Role of Bacterial Biofilms in Colorectal Cancer Screening
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Clinician's RoundtableRisk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Optimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Clinician's RoundtableOptimizing Colorectal Cancer Screening: A Stress Test of Current Guidelines
Pedro Nascimento de Lima, PhD
Improving Colorectal Cancer Screening Adherence: Advantages of FIT
Clinician's RoundtableImproving Colorectal Cancer Screening Adherence: Advantages of FIT
Theodore Levin, MD
- advertisement
Postcolonoscopy Colorectal Cancer: Optimizing Quality to Reduce Risk
Clinician's RoundtablePostcolonoscopy Colorectal Cancer: Optimizing Quality to Reduce Risk
Aasma Shaukat, MD, MPH
Disaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Clinician's RoundtableDisaster-Proofing Colorectal Cancer Screening: What We Learned from COVID-19
Charles Turck, PharmD, BCPS, BCCCP
Gloria Coronado, PhD
The Stepping Stones to Better Colorectal Cancer Screening
Clinician's RoundtableThe Stepping Stones to Better Colorectal Cancer Screening
Harish Gagneja, MD
